CSIMarket Company Name, Ticker, Suppliers, else..


Genedx Holdings Corp   (NASDAQ: WGS)
Other Ticker:  
 

Genedx Holdings Corp

WGS's Fundamental analysis



Looking into Genedx Holdings growth rates, revenue grew by 66.3 % in IV. Quarter 2024 from the same quarter a year ago. Ranking at No. 375

Medical Equipment & Supplies industry recorded deterioration of revenues by -2.28 %

Genedx Holdings realized net income compared to net loss a year ago in IV. Quarter 2024

• More on WGS's Growth


Genedx Holdings
realized a net loss in trailing twelve months.

Genedx Holdings realized cash reduction of $ -0.54 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 8.69.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.13.


• More on WGS's Valuation
 
 Total Debt (Millions $) 52
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 1,526,985
 Net Income/Employee (TTM) $ -261,430
 Receivable Turnover (TTM) 9.45
 Tangible Book Value (Per Share $) 3.21

Genedx Holdings
realized net loss in trailing twelve months.

Genedx Holdings realized cash outflow of $ -0.54per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 8.69.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.13.

Genedx Holdings Price to Book Ratio is at 10.82 higher than Industry Avg. of -156.92, and higher than S&P 500 Avg. of 0.01

• More on WGS's Valuation

•  Market Capitalization (Millions $) 2,654
•  Shares Outstanding (Millions) 27
•  Employees 200
•  Revenues (TTM) (Millions $) 305
•  Net Income (TTM) (Millions $) -52
•  Cash Flow (TTM) (Millions $) -14
•  Capital Exp. (TTM) (Millions $) -5
•  Total Debt (Millions $) 52
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 1,526,985
•  Net Income/Employee(TTM) $ -261,430
•  Receivable Turnover Ratio (TTM) 9.45
•  Tangible Book Value (Per Share $) 3.21

•  Market Capitalization (Millions $) 2,654
•  Shares Outstanding (Millions) 27
•  Employees 200
•  Revenues (TTM) (Millions $) 305
•  Net Income (TTM) (Millions $) -52
•  Cash Flow (TTM) (Millions $) -14
•  Capital Exp. (TTM) (Millions $) -5


    WGS's Profitability Comparisons
Genedx Holdings achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2024 to 9.15 %.

Genedx Holdings net profit margin of 5.65 % is currently ranking no. 43 in Medical Equipment & Supplies industry, ranking no. 121 in Healthcare sector and number 1405 in S&P 500.


Profitability by Segment
GeneDx 62.09 %
Legacy Sema4 100 %



  Ratio
•   Capital Ratio (MRQ) 3.61
•  Total Debt to Equity (MRQ) 0.21
•  Tangible Leverage Ratio (MRQ) 2.01
•  Asset Turnover Ratio (TTM) 0.76
•  Inventory Turnover Ratio (TTM) 10.24



Genedx Holdings achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2024 to 9.15 %.

Genedx Holdings net profit margin of 5.65 % is currently ranking no. 43 in Medical Equipment & Supplies industry, ranking no. 121 in Healthcare sector and number 1405 in S&P 500.

• More on WGS's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com